About this episode

Mark and Howard discuss the role of intelligence in the biotech sector with guest Sarah Holland.

Mark and Howard are joined by Sarah Holland, Chief Business Officer at Swiss biotech CDR Life and President of the Swiss Healthcare Licensing Group, to explore what intelligence looks like in the private sector. Sarah explains how biotech companies use competitive intelligence, scientific data, market insight, expert networks, conferences, regulatory signals, and even industry gossip to make high-stakes decisions about drug development and partnerships.

More episodes of The Collators

• Roy Casagranda - Honest Eulogies Lead to Better Futures · July 2, 2026 · 1h 39m
• Orwell Everywhere All At Once - Interview with Mike Hawkes · June 19, 2026 · 1h 23m
• Insight on cue: Interview with Carmen Medina · June 14, 2026 · 1h 3m
• Interview with Dean Baratta · June 4, 2026 · 51 min
• Propaganda - Interview with Konstantin Samoilov · May 26, 2026 · 1h 7m
• Imagination Matters: Interview with Ian Jackson · May 15, 2026 · 59 min

Explore listener stats, chart rankings, contacts and more on the The Collators podcast page.